Skip to main content
Skip to content
Case File
efta-01522122DOJ Data Set 10Other

EFTA01522122

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01522122
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL- OAP FDG ACCT For the Period 12/1/I1 to 12/31/11 Equity Summary Asset Categories US Large Cap Equity 149,066.00 160,064.44 10,976.44 97% Concentrated 8 Other Equity 6,135.38 0.00 (6,135.38) Total Value $155,221.38 $160,064.44 $4,843.08 97% Beginning Ending Change Current Market Value Market Value In Value Allocation Market Value/Cost Current Period Value Market Value 160.064.44 Tax Cost 146.020.49 Unrealized GainrLoss 14.043.95 Estimated Annual Income 536503 Accrued Dividends 239.79 Yield 3.36% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 002824-10-0 ABT 56.23 148.000 8,322.04 7,308.74 1,013.30 284.16 3.41% ANALOG DEVICES INC 032654-10-5 ADI 35.78 176.000 6,297.28 6,011.39 285.89 176.00 2.79% AUTOMATIC DATA PROCESSING INC 053015-10-3 ADP 54.01 150.000 8,101.50 7,264.05 837.45 237.00 59.25 2.93% J.P.Morgan Page 6 of 15 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049603 SDNY_GM_00318801 EFTA01522122

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.